Search filters

List of works by Tanya Siddiqi

A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors

scientific article published on 16 April 2019

A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma.

scientific article

Autologous Stem Cell Transplantation After Second Line Brentuximab Vedotin in Relapsed or Refractory Hodgkin Lymphoma.

scientific article published on 20 December 2017

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

scientific article published on 10 December 2017

Brentuximab vedotin activity in diffuse large B-cell lymphoma with CD30 undetectable by visual assessment of conventional immunohistochemistry

scientific article

Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma

scientific article

Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.

scientific article

Cancer-Associated Venous Thromboembolic Disease, Version 1.2015.

scientific article published on September 2015

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 February 2020

Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer

scientific article published on 19 April 2021

Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

scientific article published in November 2017

Impact of Pretransplantation (18)F-fluorodeoxy Glucose-Positron Emission Tomography Status on Outcomes after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma

scientific article

Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.

scientific article

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

scientific article published on 02 December 2018

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.

scientific article published on 28 June 2018

NCCN Guidelines Insights: Cancer-Associated Venous Thromboembolic Disease, Version 2.2018

scientific article published on 01 November 2018

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

scientific article published on 01 January 2019

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.

scientific article published on 20 March 2014

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

scientific article published on 4 January 2017

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

scientific article published on 26 April 2016

Phase 1 study of the Aurora kinase A inhibitor alisertib (MLN8237) combined with the histone deacetylase inhibitor vorinostat in lymphoid malignancies

scientific article published on 16 October 2019

Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma.

scientific article

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma.

scientific article published on 20 February 2014

Targeted Therapies in CLL: Monotherapy Versus Combination Approaches

scientific article published on 01 December 2018

The cerebroventricular environment modifies CAR T cells for potent activity against both central nervous system and systemic lymphoma

scientific article published on 22 October 2020

Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial

scientific article published on 01 February 2019

Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia

scientific article published on 01 November 2019

Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With Cancer

scientific article published on 22 March 2019

Venetoclax in Previously Treated Waldenström Macroglobulinemia

Venous thromboembolic disease

scientific article published on 01 November 2013

Paulina is supported by:

About Paulina

Help